droxidopa
NDC 63304-104, droxidopa, capsule, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 63304-104
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214384
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63304-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DROXIDOPA200 ug/1
Pharmacologic classes
Catecholamines [CS]; Increased Blood Pressure [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63304-104-90 | 63304010490 | 90 CAPSULE in 1 BOTTLE (63304-104-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/51ef3096-4622-4f45-a180-ab0dc6d46df9
Use it
Look up 63304-104 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63304-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63304-104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.